Message: | 1.PharmaLegacy Laboratories (Shanghai) Co., Ltd was founded in 10 years ago, After a period of rapid development, it has developed into a considerable size and effectiveness company of Rheumatoid arthritis Modelx2a386danandSyngeneic mouse model, NOw it is benchmark companies in 商务服务,医疗服务,医疗保健 industry.
2.Innovation is the cornerstones of PharmaLegacy Laboratories (Shanghai) Co., Ltds success. In the future, PharmaLegacy also hope to continue to innovate, for the majority of customers to provide CDX Modelservice. Over the years, PharmaLegacy always believe that only adhere to innovation and professional, in order to better meet customer demand for Considerate service Rheumatoid arthritis Model. details:Rheumatoid arthritis model (RA) is a systemic inflammatory disorder characterized by chronic inflammation of the synovium, which over time results in damage to the joints, leading to pain and disability. It occurs in approximately 1% of adults, and approximately 2.5 times more women than men are affected. Immune factors involved in the progression of RA are mainly manufactured by CD4+ T cells, monocytes, macrophages, or fibroblasts. Cytokines produced by these cells such as tumor necrosis factor α (TNF-α) and interleukin-1 are the keys to the damaging cascade that ultimately triggers the production of matrix metalloproteinases and osteoclasts resulting in irreversible damage to soft tissues and bones.Understanding of molecular pathogenesis of rheumatoid arthritis model has enabled development of innovative agents to modulate specific components of the disease progress for early intervention or treatment. Various experimentally induced rheumatoid arthritis models have been used extensively as the mainstay for evaluation of those therapeutic candidates.
3.Adhering to the "Customer Supreme Forge Ahead" management idea, PharmaLegacy insists on providing the best quality and service of CDX Model,Humanized mouse model with the "customer first" principle. Wholeheartedl |